Status:
COMPLETED
Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: TESTsmART Aim 2 - Kenya
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Moi University
Conditions:
Malaria
Febrile Illness
Eligibility:
All Genders
1+ years
Phase:
NA
Brief Summary
Highly subsidized first-line antimalarials (artemisinin combination therapy or ACT) are available over the counter in the private retail sector in most malaria-endemic countries. Overconsumption of AC...
Detailed Description
RATIONALE: The investigators hypothesize that decision-making in the retail sector is influenced primarily by price (or profit) supplemented by individual beliefs or preferences. Information from a d...
Eligibility Criteria
Inclusion
- All clients attending a participating outlet on the day selected for exit interviews will be eligible to be screened for inclusion into the interview sample.
- Participants with fever, or history of fever in the last 48 hours, or suspects they may have malaria
- Individual with malaria-like illness must be present at recruitment
- Older than one year of age
Exclusion
- Any individual with signs of severe illness requiring immediate referral
- Individuals who have taken an antimalarial in the last seven days, including for the current illness
- Patients \<18 years without a parent or legal guardian present
Key Trial Info
Start Date :
January 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
5696 Patients enrolled
Trial Details
Trial ID
NCT04428307
Start Date
January 11 2021
End Date
August 31 2022
Last Update
February 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moi University
Eldoret, Kenya